Comparison of the ocular hypotensive effect of brimonidine, dorzolamide, latanoprost, or artificial tears added to timolol in glaucomatous monkey eyes

Journal of Glaucoma

Volumn 9, Issue 6, 2000, Pages 458-462

  Wang, R F ^a   Serle, J B ^a   Gagliuso, D J ^a   Podos, S M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Additive ocular hypotensive effect; Brimonidine; Dorzolamide; Glaucomatous monkey eyes; Latanoprost; Timolol

Indexed keywords

ARTIFICIAL TEAR; BRIMONIDINE; DORZOLAMIDE; LATANOPROST; REFRESH TEARS; TIMOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; GLAUCOMA; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; MONKEY; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034445967     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00061198-200012000-00007     Document Type: Article

References (22)

1. Brimonidine tartrate: A one-month dose response study
2. Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor
3. A double-masked, randomized 1- year study comparing dorzolamide (Trusopt), timolol and betaxolol
4. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: A six-month, masked, multicenter trial in the United States
5. Latanoprost treatment of glaucoma: Effects of treating for 1 year and switching from timolol
6. 2-adrenergic agonists B-HT 920 and UK 14304-18: Effects on aqueous humor dynamics in monkeys
7. The ocular hypotensive effect of the topical carbonic anhydrase inhibitor L-671, 152 in glaucomatous monkeys
8. A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes
9. Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents
10. Comparison of the effect of Alphagan 0.2% versus Trusopt 2.0% in combination with beta-blockers
11. Comparative acute effects of 0.2% brimonidine versus 2% dorzolamide combined to beta-blockers in ocular hypertension
12. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure
13. The efficacy and safety of dorzolamide as adjunctive therapy to timolol maleate gellan solution in patients with elevated intraocular pressure
14. The efficacy and safety of the dorzolamide - Timolol combination versus the concomitant administration of its components
15. A randomized trial comparing the dorzolamide- Timolol combination given twice daily to monotherapy with timolol and dorzolamide
16. 2α analogue, and timolol in patient with elevated intraocular pressure
17. Around the clock intraocular pressure reduction with once daily application of latanoprost by itself or in combination with timolol
18. Intraocular pressure effects of multiple doses of drugs applied to glaucomatous monkey eyes
19. A comparison of argon laser and diode laser photocoagulation of the trabecular meshwork to produce the glaucoma monkey model
20. The ocular hypertension treatment study: Design and baseline description of the participants
21. Comparison of the efficacy and the tolerability of Alphagan and Trusopt as adjunct therapy with beta-blockers in patients with chronic open-angle glaucoma or ocular hypertension
22. Efficacy and tolerability of Alphagan versus Xalatan as adjunct therapy in chronic open-angle glaucoma or ocular hypertension patients uncontrolled on beta-blockers alone